MOLEMAP

MOLEMAP provides melanoma and non-melanoma skin cancer surveillance, detection, and treatment services. This includes taking images for screening, mapping to diagnose lesions, observing future changes and improving accuracy of suspicious lesion referrals to dermatologists and skin cancer specialists. Molemap has its own AI technology, built off its largest global lesion database, which aids in lesion diagnosis and its own treatment programmes through its surgically led skin cancer clinics. Molemap has over 120 clinics and is expanding this footprint across Australasia.

Locations: New Zealand, Australia.
More information: molemap.co.nz
More information: molemap.net.au
Investment status: Current (private equity)